Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Atlanta, GA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Atlanta, GA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Honolulu, HI
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Honolulu, HI
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Coeur D'Alene, ID
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Coeur D'Alene, ID
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Jeffersonville, IN
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jeffersonville, IN
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Louisville, KY
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Louisville, KY
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Chevy Chase, MD
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Chevy Chase, MD
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Boston, MA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Boston, MA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Detroit, MI
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Detroit, MI
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Jackson, MS
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jackson, MS
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Omaha, NE
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Omaha, NE
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Albuquerque, NM
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albuquerque, NM
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Charlotte, NC
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Lima, OH
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Lima, OH
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Charleston, SC
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charleston, SC
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Sioux Falls, SD
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Sioux Falls, SD
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Nashville, TN
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Nashville, TN
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Ogden, UT
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Ogden, UT
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Richmond, VA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Richmond, VA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
Efficacy of Botulinum Toxin Injections in the Rectus Femoris to Treat Stiff Knee Gait Following Acquired Brain Injury
Randomized Controlled Trial on the Effects of Botulinum Toxin Injections in the Rectus Femoris on Gait Function in Stiff Knee Gait Following Acquired Brain Injury
Status: Archived
Mary Free Bed Rehabilitation Hospital
mi
from
Grand Rapids, MI
Efficacy of Botulinum Toxin Injections in the Rectus Femoris to Treat Stiff Knee Gait Following Acquired Brain Injury
Randomized Controlled Trial on the Effects of Botulinum Toxin Injections in the Rectus Femoris on Gait Function in Stiff Knee Gait Following Acquired Brain Injury
Status: Archived
Updated: 1/1/1970
Mary Free Bed Rehabilitation Hospital
mi
from
Grand Rapids, MI
Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
A Phase I/II Randomized, Double-blind, Controlled Study to Evaluate Efficacy and Safety of Vitamin D on Bone Mineral Density and Markers of Bone Resorption in Aromatase Inhibitor-induced Bone Loss in Women With Breast Cancer.
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
A Phase I/II Randomized, Double-blind, Controlled Study to Evaluate Efficacy and Safety of Vitamin D on Bone Mineral Density and Markers of Bone Resorption in Aromatase Inhibitor-induced Bone Loss in Women With Breast Cancer.
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
Status: Archived
The Cleveland Clinic
mi
from
Cleveland, OH
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
Status: Archived
Updated: 1/1/1970
The Cleveland Clinic
mi
from
Cleveland, OH
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Rhode Island Hospital
mi
from
Providence, RI
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Rhode Island Hospital
mi
from
Providence, RI
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Little Rock, AR
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Little Rock, AR
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
La Mesa, CA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
La Mesa, CA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Teva Investigational Site
mi
from
La Mesa, CA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
mi
from
La Mesa, CA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Boynton Beach, FL
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Boynton Beach, FL
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Champaign, IL
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Champaign, IL
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Louisville, KY
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Louisville, KY
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Baton Rouge, LA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Baton Rouge, LA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
St. Louis, MO
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
St. Louis, MO
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Lincoln, NE
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Lincoln, NE
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Lawrence, NJ
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Lawrence, NJ
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Teva Investigational Site
mi
from
Port Jefferson, NY
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
mi
from
Port Jefferson, NY
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Durham, NC
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Durham, NC
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Cleveland, OH
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Cleveland, OH
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Medford, OR
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Medford, OR
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Pittsburgh, PA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Pittsburgh, PA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Teva Investigational Site
mi
from
Uniontown, PA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
mi
from
Uniontown, PA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Columbia, SC
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Columbia, SC
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Dallas, TX
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Dallas, TX
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Salt Lake City, UT
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Salt Lake City, UT
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Norfolk, VA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Norfolk, VA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Duramed Research Investigational Site
mi
from
Seattle, WA
A Multicenter Study to Evaluate the Effects of DR-105 on Bone Mineral Density in Adolescent Females
A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females
Status: Archived
Updated: 1/1/1970
Duramed Research Investigational Site
mi
from
Seattle, WA
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Clinical Evaluation of the Crosstrees Pod™ in the Treatment of Pathologic Fracture of the Vertebral Body (Levels T4 - L5) in Adult Patients
Clinical Evaluation of the Crosstrees® System for PVA in Symptomatic Adult Patients With Acute Vertebral Body Compression Fractures at T4-L5
Status: Archived
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Clinical Evaluation of the Crosstrees Pod™ in the Treatment of Pathologic Fracture of the Vertebral Body (Levels T4 - L5) in Adult Patients
Clinical Evaluation of the Crosstrees® System for PVA in Symptomatic Adult Patients With Acute Vertebral Body Compression Fractures at T4-L5
Status: Archived
Updated: 1/1/1970
Long Beach Memorial Medical Center
mi
from
Long Beach, CA